Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Clinical Data Begins Pivotal Study Of Depression Drug

March 31, 2006

By Jennifer Boggs

Riding High, Amylin Adding $465M Via Public Stock Sale

March 31, 2006

By Jennifer Boggs

Riding High, Amylin Adding $465M Via Public Stock Sale

March 31, 2006

By Jennifer Boggs

Clinical Data Begins Pivotal Study Of Depression Drug

March 31, 2006

By Jennifer Boggs

Arteriocyte’s Focus: Stem Cells For Ischemic Repair

March 30, 2006

By Jennifer Boggs

Arteriocyte’s Focus: Stem Cells For Ischemic Repair

March 30, 2006

By Jennifer Boggs

Sequenom’s $30M In Private Money For Genetic Analysis

March 29, 2006

By Jennifer Boggs

Biotech Pipelines Sitting ‘Unexploited’ In Australia

March 29, 2006

By Jennifer Boggs

Biotech Pipelines Sitting Unexploited’ In Australia

March 29, 2006

By Jennifer Boggs

Sequenom’s $30M In Private Money For Genetic Analysis

March 29, 2006

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...